Berkshire Hathaway vs Roche: Founders, CEOs and History
Berkshire Hathaway was founded in 1839 by Oliver Chace, Warren Edward Buffett and is led by Greg Abel. Roche was founded in 1896 by Fritz Hoffmann-La Roche and is led by Thomas Schinecker.
Company facts
Berkshire Hathaway
- Founded
- 1839
- Headquarters
- Omaha, Nebraska
- Current CEO
- Greg Abel
- Employees
- 387,800
Roche
- Founded
- 1896
- Headquarters
- Basel, Switzerland
- Current CEO
- Thomas Schinecker
- Employees
- 112,774
Founders
Berkshire Hathaway
Oliver Chace
Berkshire Hathaway is famous not for the men who originally founded it, but for the man who conquered and reinvented it. The original company, the Valley Falls Company, was a textile manufacturer established by Oliver Chace in Rhode Island in 1839.
Warren Edward Buffett
Warren Buffett effectively refounded Berkshire Hathaway beginning in 1965 when his investment partnership gained control of the struggling New England textile company and he became its chairman and CEO.
Roche
Fritz Hoffmann-La Roche
Fritz Hoffmann-La Roche (1868-1920) founded F. Hoffmann-La Roche & Co. in Basel on 1 October 1896, at age 28.
CEOs and their tenures
Berkshire Hathaway
- Seabury Stanton1955–1965
President
Stanton ran Hathaway Manufacturing from the 1930s and led the 1955 merger with Berkshire Fine Spinning Associates that created Berkshire Hathaway Inc. He closed plants and used liquidation proceeds to buy back stock as New England textiles declined.
Source - Warren Buffett1965–2025
Chairman and Chief Executive Officer
Buffett took control of Berkshire Hathaway in 1965 and turned a shrinking textile maker into a holding company built on insurance float.
Source - Greg Abel2026–present
President and Chief Executive Officer
Abel became President and CEO on January 1, 2026 after the board approved the succession in May 2025.
Source
Roche
- Severin Schwan2008–2023
Chief Executive Officer
Serving as CEO from 2008 to 2023, he cemented Roche's absolute dominance in global oncology and highly advanced diagnostics before moving to Chairman of the Board.
Source - Thomas Schinecker2023–present
Chief Executive Officer
Under Schinecker, Roche returned to growth after the COVID testing decline: 2025 sales rose 7% at constant rates to ~$73.8 billion (CHF 61.5 billion) and 12 late-stage studies read out positively that year.
Source
Timeline: Berkshire Hathaway and Roche side by side
1839Berkshire Hathaway
Valley Falls Company Founded
Oliver Chace founds the Valley Falls Company in Valley Falls, Rhode Island, as a cotton textile manufacturer. Chace had learned the trade working with Samuel Slater and built his first mill in 1806.
1896Roche
F. Hoffmann-La Roche Founded in Basel
Fritz Hoffmann-La Roche founds the enterprise in Basel, Switzerland, pioneering mass-manufactured, chemically standardized prescription pharmaceuticals.
1898Roche
Commercial Breakthrough with Sirolin
Roche launches non-prescription cough syrup Sirolin, achieving widespread international distribution and financing early clinical laboratories.
1934Roche
First Industrial Synthesis of Vitamin C
Roche becomes the first company to mass-produce synthetic Vitamin C (Redoxon) at industrial scale, anchoring decades of high-margin global cash flow.
1955Berkshire Hathaway
Berkshire Fine Spinning and Hathaway Manufacturing Merge
Berkshire Fine Spinning Associates and Hathaway Manufacturing combine and take the Berkshire Hathaway name.
1962Berkshire Hathaway
Buffett Partnership Buys Its First Berkshire Shares
Buffett Partnership Ltd. buys its first Berkshire Hathaway shares in December 1962. Buffett was drawn to the pattern of Berkshire closing plants and using the liquidation proceeds to repurchase its own stock.
1963Roche
Launch of Valium (Diazepam)
Roche introduces Valium, which becomes the world's most widely prescribed psychotropic medication and establishes global pharmaceutical leadership.
1964Berkshire Hathaway
Tender Offer Dispute With Seabury Stanton
Berkshire president Seabury Stanton asks Buffett at what price Buffett Partnership would sell, agrees to $11.50 a share, then mails a tender offer at $11.375.
1965Berkshire Hathaway
Buffett Takes Control and Names Ken Chace President
Buffett Partnership takes control of Berkshire Hathaway in May 1965 and Stanton leaves. Buffett selects Ken Chace, a long-time employee, as president to run the textile operation, and the cash it generates is pointed at other industries.
1967Berkshire Hathaway
Entry Into Insurance With National Indemnity
Early in 1967 Berkshire pays $8.6 million to buy National Indemnity Company and a small sister insurer from owner Jack Ringwalt.
1968Roche
Establishment of Roche Diagnostics
Roche launches its dedicated diagnostic division, laying the foundation to become the world's preeminent in-vitro diagnostics (IVD) provider.
1972Berkshire Hathaway
See's Candies Bought for $25 Million
Blue Chip Stamps, controlled by Buffett and Munger and later merged into Berkshire, buys See's Candies for $25 million.
1985Berkshire Hathaway
Textile Operations Closed
Buffett decides in July 1985 to close Berkshire's textile operation and the shutdown is largely complete by year end. He described it as finally throwing in the towel after twenty years of unremitting struggle with the business.
1996Berkshire Hathaway
GEICO Becomes Wholly Owned and Class B Shares Created
Berkshire buys the remaining 49% of GEICO on January 2, 1996, having held 51%, and GEICO becomes a wholly owned subsidiary. Shareholders also approve a recapitalization creating Class B shares with the economic rights of one thirtieth of a Class A share.
1998Berkshire Hathaway
General Re and Executive Jet Acquired
Berkshire acquires reinsurer General Re and fractional-aircraft operator Executive Jet.
2008Roche
Severin Schwan becomes CEO
Severin Schwan became CEO of F. Hoffmann-La Roche in 2008. Led Roche for 14 years; handed over to Thomas Schinecker in March 2023 and became chairman.
2009Roche
Full Acquisition of Genentech for $46.8 Billion
Roche completes its historic $46.8 billion buyout of American biotechnology pioneer Genentech, securing market leadership in oncology biologics.
2010Berkshire Hathaway
BNSF Railway Acquired
Berkshire completes its purchase of Burlington Northern Santa Fe in the first quarter of 2010.
2016Berkshire Hathaway
Precision Castparts Acquired
Berkshire completes the purchase of Precision Castparts, an aerospace and industrial components maker, for $235 a share in cash.
2018Berkshire Hathaway
Abel and Jain Named Vice Chairmen
Berkshire's board expands from twelve to fourteen directors and elects Greg Abel and Ajit Jain.
2018Roche
Foundation Medicine & Flatiron Health Acquisitions
Roche acquires Foundation Medicine and Flatiron Health, integrating real-world oncology data analytics and genomic profiling into personalized healthcare.
2022Berkshire Hathaway
Alleghany Corporation Acquired
Berkshire completes the acquisition of insurer Alleghany Corporation on October 19, 2022, paying $848.02 a share in cash for a total equity value of about $11.6 billion and adding the TransRe reinsurance business.
2023Roche
Acquired Telavant
F. Hoffmann-La Roche acquired Telavant for $7.1 billion. Roche paid $7.1 billion upfront for Telavant to gain US and Japan rights to the anti-TL1A antibody RVT-3101 (afimkibart) for inflammatory bowel disease.
2024Berkshire Hathaway
Market Value Tops $1 Trillion
Berkshire's market capitalization passes $1 trillion on August 28, 2024, making it the first US company outside the technology sector to reach that level.
2024Berkshire Hathaway
Pilot Travel Centers Fully Owned
Berkshire acquires the remaining 20% of Pilot Travel Centers on January 16, 2024 and takes full ownership. It had bought 38.6% in 2017 and a further 41.4% for about $8.2 billion in January 2023.
2025Berkshire Hathaway
Board Approves Abel as CEO From January 2026
Berkshire announces in May 2025 that Greg Abel will become President and Chief Executive Officer on January 1, 2026, with Warren Buffett remaining Chairman of the Board.
2025Roche
Group Sales Reach CHF 61.5 Billion
Under CEO Thomas Schinecker, Roche delivers group sales of ~$73.8 billion (CHF 61.5 billion), driven by ~$57.2B (CHF 47.7B) in Pharmaceuticals and ~$16.6B (CHF 13.8B) in Diagnostics.
2026Berkshire Hathaway
Abel Becomes CEO and Buffett Becomes Chairman Emeritus
Abel takes over as CEO on January 1, 2026 and Berkshire completes the $9.7 billion purchase of OxyChem from Occidental on January 2. On September 18, 2026 Buffett is named Chairman Emeritus and remains a director, and his son Howard G.
Acquisitions
Berkshire Hathaway
- OxyChem (Occidental Chemical Corporation)2026$9.7B
- Alleghany Corporation2022$11.6B
- Precision Castparts Corp.2016$37.2B
- Burlington Northern Santa Fe Corporation (BNSF)2010$44B
- McLane Company2003$1.5B
- General Re Corporation1998$22B
Roche
- PathAI2026$1.1B
- 89bio2025$3.5B
- Telavant2023$7.1B
- Carmot Therapeutics2023$2.7B
- Foundation Medicine2018$2.4B
- ForSight VISION42017Undisclosed
Questions about Berkshire Hathaway vs Roche
Who is the CEO of Berkshire Hathaway Inc. and F. Hoffmann-La Roche AG?
Berkshire Hathaway Inc. is led by Greg Abel and F. Hoffmann-La Roche AG is led by Thomas Schinecker. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Berkshire Hathaway Inc. founded vs F. Hoffmann-La Roche AG?
Berkshire Hathaway Inc. was founded in 1839 — 57 years before F. Hoffmann-La Roche AG, which was founded in 1896. Berkshire Hathaway Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger F. Hoffmann-La Roche AG.
How many employees does Berkshire Hathaway Inc. have compared to F. Hoffmann-La Roche AG?
Berkshire Hathaway Inc. employs approximately 387,800 people, while F. Hoffmann-La Roche AG employs approximately 112,774. Berkshire Hathaway Inc. has the larger workforce at 387,800 employees, compared to F. Hoffmann-La Roche AG's 112,774. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Berkshire Hathaway Inc. and F. Hoffmann-La Roche AG headquartered?
Berkshire Hathaway Inc. is headquartered in United States and F. Hoffmann-La Roche AG is headquartered in Switzerland. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded Berkshire Hathaway Inc. and F. Hoffmann-La Roche AG?
Berkshire Hathaway Inc. was founded by Oliver Chace, Warren Edward Buffett. F. Hoffmann-La Roche AG was founded by Fritz Hoffmann-La Roche.
Which company has a longer operating history — Berkshire Hathaway Inc. or F. Hoffmann-La Roche AG?
Berkshire Hathaway Inc. has been operating for approximately 187 years, making it the more established of the two companies. F. Hoffmann-La Roche AG has been in operation for around 130 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Berkshire Hathaway vs Roche overview